Drug Pipeline

ABBV-706 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-19 NCT07155174
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of…		 Trial sites expanded: 34 -> 49 locations
2026-05-14 NCT07155174
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of…		 Trial sites reduced: 42 -> 34 locations
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07365241 A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706… Small Cell Lung Cancer Not Yet Recruiting
Phase 2
NCT07155174 A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of… Small Cell Lung Cancer Recruiting
Phase 1
NCT05599984 Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves… Advanced Solid Tumors Active, Not Recruiting
Sponsors Running ABBV-706 Trials
AbbVie (3)
Disease Areas
Small Cell Lung Cancer (2) Lung Cancer (2)
Get alerts when ABBV-706 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free